{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T15:21:00Z","timestamp":1648567260293},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ijantimicag.2003.11.009","type":"journal-article","created":{"date-parts":[[2004,6,17]],"date-time":"2004-06-17T20:34:35Z","timestamp":1087504475000},"page":"39-42","source":"Crossref","is-referenced-by-count":3,"title":["Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and -resistant Streptococcus pneumoniae in relation to their resistance genotypes"],"prefix":"10.1016","volume":"24","author":[{"given":"Bur\u00e7in","family":"\u015eener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zgen","family":"K\u00f6seo\u01e7lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/CMR.3.2.171","article-title":"Pneumococcal resistance to antibiotics","volume":"3","author":"Klugman","year":"1990","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.43.2.357","article-title":"Aguilar L and the Spanish surveillance group for respiratory pathogens. Antimicrobial resistance of 1113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1 year (1996\u20131997) multicenter surveillance study","volume":"43","author":"Baquero","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/514953","article-title":"Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance programme","volume":"27","author":"Doern","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/44.1.1","article-title":"Pneumococcal macrolide resistance: myth or reality?","volume":"44","author":"Amsden","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB5","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/AAC.46.9.2727-2734.2002","article-title":"Resistance to macrolides and related antibiotics in Streptococcus pneumoniae","volume":"46","author":"Leclerq","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB7","unstructured":"Weisblum B. Resistance to macrolide-lincosamide-streptogramin antibiotics. In: Fischetti V, editor. Gram positive pathogens. Washington, DC, USA: ASM Press, 2000, p. 694\u2013710."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB8","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/AAC.43.10.2510","article-title":"Patterns of macrolide resistance determinants among community acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates","volume":"43","author":"Oster","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/AAC.45.2.636-638.2001","article-title":"Mechanisms of macrolide resistance in clinical pneumococcal isolates in France","volume":"45","author":"Fitoussi","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB10","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.42.9.2425","article-title":"Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae","volume":"42","author":"Johnston","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB11","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/AAC.45.7.2147-2150.2001","article-title":"Macrolide-resistant Streptococcus pneumoniae in Canada during 1998\u20131999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides","volume":"45","author":"Hoban","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1517\/13543784.8.8.1171","article-title":"New research in macrolides and ketolides since 1997","volume":"8","author":"Bryskier","year":"1999","journal-title":"Expert Opin. Investig. Drug"},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/14656566.2.2.293","article-title":"Linezolid\u2014a review of the first oxazolidinone","volume":"2","author":"Norrby","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB14","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5, fifth ed. Wayne, PA, USA: NCCLS, 2000."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB15","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/JCM.38.5.1731-1734.2000","article-title":"Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children","volume":"38","author":"Waites","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB16","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","article-title":"Detection of erythromycin-resistant determinants by PCR","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/joc.1999.11.2.107","article-title":"The role of newer macrolides in the treatment of community acquired respiratory tract infection: a review of experimental and clinical data","volume":"11","author":"Carbon","year":"1999","journal-title":"J. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1471-4892(02)00198-4","article-title":"Ketolides: the future of the macrolides","volume":"2","author":"Nilius","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.40.4.839","article-title":"In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents","volume":"40","author":"Zurenko","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1128\/AAC.42.4.945","article-title":"Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin\u2013dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)","volume":"42","author":"Barry","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jac\/42.3.381","article-title":"Trends in antimicrobial resistance of Streptococcus pneumoniae in children in a Turkish hospital","volume":"42","author":"\u015eener","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1179\/joc.2001.13.5.541","article-title":"Streptococcus pneumoniae penicillin resistance in Turkey","volume":"13","author":"G\u00fcr","year":"2001","journal-title":"J. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1086\/516945","article-title":"Spread of multidrug resistant Streptococcus pneumoniae in South Korea","volume":"25","author":"Song","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB24","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1128\/AAC.45.9.2427-2431.2001","article-title":"In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms","volume":"45","author":"Morosini","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/mdr.1995.1.71","article-title":"Novel penicillin resistant clones of Streptococcus pneumoniae in the Czech Republic and in Slovakia","volume":"1","author":"Figueriedo","year":"1995","journal-title":"Microbial. Drug Resist."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/JCM.37.3.638-648.1999","article-title":"Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates from Bulgaria","volume":"37","author":"Setchanova","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB27","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/AAC.46.9.2963-2968.2002","article-title":"Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia","volume":"46","author":"Kozlov","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2003.11.009_BIB28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1179\/joc.1999.11.Supplement-2.35","article-title":"Evolving resistance patterns of Streptococcus pneumoniae: a link with longacting macrolide consumption","volume":"11","author":"Baquero","year":"1999","journal-title":"J. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/AAC.42.3.624","article-title":"Susceptibilities of penicillin and erythromycin susceptible and resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents","volume":"42","author":"Pankuch","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.11.009_BIB30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/49.2.399","article-title":"In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime","volume":"49","author":"Fuchs","year":"2002","journal-title":"J. Antimicrob. Chemother."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904001104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857904001104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T12:58:58Z","timestamp":1585832338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857904001104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0924857904001104"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.11.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}